Suppr超能文献

中东呼吸综合征冠状病毒刺突糖蛋白通过DPP4介导的IRAK-M和PPARγ诱导抑制巨噬细胞反应。

Middle east respiratory syndrome corona virus spike glycoprotein suppresses macrophage responses via DPP4-mediated induction of IRAK-M and PPARγ.

作者信息

Al-Qahtani Ahmed A, Lyroni Konstantina, Aznaourova Marina, Tseliou Melpomeni, Al-Anazi Mashael R, Al-Ahdal Mohammed N, Alkahtani Saad, Sourvinos George, Tsatsanis Christos

机构信息

Department of Infection and Immunity, Research Center, King Faisal Specialist Hospital and Research Center, Saudi Arabia.

Department of Microbiology and Immunology, School of Medicine, Alfaisal University, Riyadh, Saudi Arabia.

出版信息

Oncotarget. 2017 Feb 7;8(6):9053-9066. doi: 10.18632/oncotarget.14754.

Abstract

Middle East Respiratory Syndrome Corona Virus (MERS-CoV) is transmitted via the respiratory tract and causes severe Acute Respiratory Distress Syndrome by infecting lung epithelial cells and macrophages. Macrophages can readily recognize the virus and eliminate it. MERS-CoV infects cells via its Spike (S) glycoprotein that binds on Dipeptidyl-Peptidase 4 (DPP4) receptor present on macrophages. Whether this Spike/DPP4 association affects macrophage responses remains unknown. Herein we demonstrated that infection of macrophages with lentiviral particles pseudotyped with MERS-CoV S glycoprotein results in suppression of macrophage responses since it reduced the capacity of macrophages to produce TNFα and IL-6 in naive and LPS-activated THP-1 macrophages and augmented LPS-induced production of the immunosuppressive cytokine IL-10. MERS-CoV S glycoprotein induced the expression of the negative regulator of TLR signaling IRAK-M as well as of the transcriptional repressor PPARγ. Inhibition of DPP4 by its inhibitor sitagliptin or siRNA abrogated the effects of MERS-CoV S glycoprotein on IRAK-M, PPARγ and IL-10, confirming that its immunosuppressive effects were mediated by DPP4 receptor. The effect was observed both in THP-1 macrophages and human primary peripheral blood monocytes. These findings support a DPP4-mediated suppressive action of MERS-CoV in macrophages and suggest a potential target for effective elimination of its pathogenicity.

摘要

中东呼吸综合征冠状病毒(MERS-CoV)通过呼吸道传播,通过感染肺上皮细胞和巨噬细胞引起严重急性呼吸窘迫综合征。巨噬细胞能够轻易识别并清除该病毒。MERS-CoV通过其刺突(S)糖蛋白感染细胞,该糖蛋白与巨噬细胞上存在的二肽基肽酶4(DPP4)受体结合。这种刺突/ DPP4结合是否会影响巨噬细胞反应尚不清楚。在此我们证明,用MERS-CoV S糖蛋白假型化的慢病毒颗粒感染巨噬细胞会导致巨噬细胞反应受到抑制,因为它降低了幼稚和LPS激活的THP-1巨噬细胞产生TNFα和IL-6的能力,并增加了LPS诱导的免疫抑制细胞因子IL-10的产生。MERS-CoV S糖蛋白诱导了TLR信号传导负调节因子IRAK-M以及转录抑制因子PPARγ的表达。其抑制剂西他列汀或siRNA对DPP4的抑制消除了MERS-CoV S糖蛋白对IRAK-M、PPARγ和IL-10的影响,证实其免疫抑制作用是由DPP4受体介导的。在THP-1巨噬细胞和人原代外周血单核细胞中均观察到了这种效应。这些发现支持了MERS-CoV在巨噬细胞中由DPP4介导的抑制作用,并提示了有效消除其致病性的潜在靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验